Search For

The BET inhibitor sensitivity is associated with the expression level of CDC25B in pancreatic cancer models

Unlocking the potential of immunotherapy in platinum-resistant ovarian cancer: rationale, challenges, and novel strategies

Emerging roles of small extracellular vesicles in metabolic reprogramming and drug resistance in cancers

Competing endogenous RNAs (ceRNAs) and drug resistance to cancer therapy

Screening of photosensitizers-ATP binding cassette (ABC) transporter interactions in vitro

Intercellular transfer of multidrug resistance mediated by extracellular vesicles

Non-coding RNA and drug resistance in head and neck cancer

Current applications of tumor local ablation (TLA) combined with immune checkpoint inhibitors in breast cancer treatment

Cancer-associated fibroblast cell surface markers as potential biomarkers or therapeutic targets in lung cancer

Research progress on the role and mechanism of circular RNA in drug resistance of head and neck squamous cell carcinoma

The role of circRNAs and miRNAs in drug resistance and targeted therapy responses in breast cancer

The uniqueness of ABCB5 as a full transporter ABCB5FL and a half-transporter-like ABCB5β